Bradesco Board Approves R$ 10 Billion Capital Increase Relevance4,0
Intermediate PTENES

Bradesco Board Approves R$ 10 Billion Capital Increase

The auction of remaining rights generated a R$ 3.3 million premium, which will be allocated to the capital reserve.

In 20 seconds
  • Bradesco's board approved the R$ 10 billion capital increase after selling all remaining rights on the B3.
  • The new shares will be credited within 3 business days following final approval from the Central Bank.
  • The new shares will be fully entitled to dividends and interest on equity declared after regulatory approval.

Banco Bradesco S.A. informed the market that its Board of Directors has approved the ratification of a R$ 10 billion capital increase, following the successful auction of all remaining share subscription rights on the B3.

What Happened with Bradesco's Capital Increase (BBDC3)?

Banco Bradesco S.A. confirmed that its Board of Directors approved the capitalization increase of R$ 10 billion during a meeting held on October 2, 2026. The decision came immediately after the auction of remaining share subscription rights on the B3.

This rights auction served to sell the subscription receipts that were not exercised by shareholders during the priority period. According to the notice to shareholders released by the bank, all offered subscription receipts were sold in full on the stock exchange.

In total, 1,505,454 common share receipts and 14,553,057 preferred share receipts were auctioned. The common shares sold at a unit price of R$ 15.50, while the preferred shares went for R$ 17.86 each, generating a total gross value of R$ 283,252,135.02.

With the complete sale of the remaining rights, Bradesco was able to proceed with the internal ratification of the capitalization process, which now moves to the external regulatory approval phase.

Previous Share CapitalR$ 93.77 BillionBradesco S.A.
→
Approved Share CapitalR$ 103.77 BillionPending BACEN Approval

What Are the Final Figures for This Bradesco Offering?

The ratification consolidates the total issuance of 604,852,753 new shares by Bradesco, split nearly evenly between common and preferred shares. The original subscription prices were set at R$ 15.43 for common shares and R$ 17.64 for preferred shares.

Of the total new shares issued, 302,876,396 are common shares and 301,976,357 are preferred shares. The total subscription value reached exactly the R$ 10,000,000,000.00 target established by the board in July 2026.

Because the auction on the B3 achieved prices slightly higher than the original issuance value, the transaction generated a premium. This premium totaled R$ 3,307,054.32, representing an additional R$ 0.07 per common share and R$ 0.22 per preferred share.

Bradesco reported that this additional amount of R$ 3.3 million will be allocated entirely to the company's capital reserve, further strengthening the institution's net worth.

Total Volume R$ 10 Billion

Total capital raised and ratified by the Board of Directors.

New Shares 604,852,753

Comprising 302,876,396 common and 301,976,357 preferred shares.

Allocated Premium R$ 3.3 Million

Additional funds raised at auction directed to capital reserves.

When Will New BBDC3 Shares Reach Investor Portfolios?

The new shares will be credited to the accounts of investors who participated in the subscription within 3 business days after final approval from the Central Bank of Brazil. Although the Board of Directors has already ratified the process, full effectiveness depends on the regulatory agency.

The Central Bank of Brazil (BACEN) must formally review and approve the change in share capital for major financial institutions. This procedure is a standard legal requirement to ensure the stability of the national banking system.

Bradesco reiterated that it will keep the market and its shareholders informed regarding the progress of this regulatory approval. As soon as the Central Bank ratifies the increase, the 3-day window for the physical crediting of the shares will begin.

Until this final approval takes place, investors who subscribed to the offering continue to hold subscription receipts. These receipts will be converted automatically into definitive shares in custody accounts once the regulator gives the green light.

1

Board Ratification — Internal step completed on October 2, 2026, following the rights auction.

2

Central Bank Approval — The process awaits review and final ratification by BACEN.

3

Share Crediting — Shares will be credited to subscribers within 3 business days following BACEN approval.

How Will Dividends and Interest on Equity Work for the New Shares?

The newly issued shares will be entitled to the full receipt of dividends and Interest on Equity (JCP) declared after BACEN's ratification. This means the new shares will participate in all future distributions of earnings on equal terms with older shares.

Entitlement to earnings begins only from the moment the Central Bank approves the increase. If the bank declares any payout prior to this regulatory ratification, the new shares will not yet be eligible for that payment.

Bradesco's shareholder base will total 11,196,864,781 outstanding shares upon completion of the entire process. This base will be split into 5,606,747,177 common shares and 5,590,117,604 preferred shares.

Because all shares are registered and have no par value, dividend distribution will continue to be paid per share. The expansion of the share base slightly dilutes the stake of anyone who chose not to participate in the capital subscription.

What This Means for BBDC3 Shareholders

What Is the Impact for BBDC3 Investors?

The practical impact for investors holding BBDC3 shares is considered neutral, as the market had already priced in the dilution since July. The R$ 10 billion capital raise was widely known and followed the schedule laid out by bank management.

Ratification by the Board of Directors represents merely the completion of a formal and expected step in the corporate procedure. Allocating the rights auction premium to capital reserves helps strengthen the balance sheet, but has a marginal short-term effect.

For long-term investors, the strengthening of share capital to R$ 103.77 billion improves the bank's solvency ratios. This more robust capital structure supports the growth of the loan portfolio and future institutional operations.

Shareholder focus should now turn to monitoring Central Bank approval. Following that date, investors will see the adjustment in their portfolios and begin receiving earnings on their total shareholdings.

Verdict: Neutral for the Investment Thesis

The board's ratification of the capital increase consolidates the R$ 10 billion capital raise and lifts share capital to R$ 103.77 billion, pending final approval from the Central Bank of Brazil. The dilution and capital structure were already anticipated by the market based on previous announcements. New shares will become eligible for earnings distributions only after regulatory approval.